• Nabi Biopharmaceuticals Announces Altastaph(TM) Phase II Trial Results in Neonates
    ROCKVILLE, Md. -- Nabi Biopharmaceuticals today Phase II clinical trial results for Altastaph(TM) [Staphylococcus aureus Immune Globulin Intravenous (Human)]. This Phase II trial was conducted in premature, low birth-weight babies (neonates). Altastaph is the company's ...More
    November 18, 2004 Posted in News
  • Positive Outcome of Phase I DNA Influenza Study
    OXFORD, England -- PowderMed Ltd. (PowderMed), a company focusing on the development of therapeutic DNA vaccines, has announced positive results in a Phase I clinical trial of a proprietary prophylactic DNA influenza vaccine. The trial examined three doses of the DNA ...More
    November 18, 2004 Posted in News
  • African Children with HIV Would Benefit from Daily Doses of Cheap Antibiotic
    Results of a randomized trial in this week’s issue of The Lancet highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia. The trial ...More
    November 18, 2004 Posted in News
  • Flu Arrives in Oregon
    PORTLAND -- Oregon's first laboratory-confirmed influenza case for the current flu season has been reported by Providence Portland Medical Center, according to public health officials at the Oregon Department of Human Services (DHS). It occurred in a 28-year-old man. "The ...More
    November 17, 2004 Posted in News
  • Hantavirus Fatality Confirmed in New Mexico Woman
    SANTA FE -- A fatal case of Hantavirus Pulmonary Syndrome has been confirmed in an adult woman from McKinley County. The case was confirmed by testing done at the University of New Mexico’s Health Sciences Center and TriCore Reference Laboratories. An environmental ...More
    November 17, 2004 Posted in News
  • Legislature Passes Joint Resolution to Finance and Construct New State Laboratory to Detect and Identify Emerging Infections, Terrorism-Related Threat
    TRENTON -- The New Jersey Legislature has passed a joint resolution authorizing the financing and construction by the New Jersey Building Authority of a new $139 million Public Health, Environmental, and Agricultural Laboratory for use by the New Jersey Department of Health ...More
    November 17, 2004 Posted in News
  • Computer Models to Simulate Hypothetical Outbreak of Avian Flu
    A group of scientists who are developing computer models to combat infectious diseases have focused their attention on the H5N1 strain of the bird influenza virus. By simulating the outbreak of this potentially deadly avian flu in a hypothetical human community, the ...More
    November 17, 2004 Posted in News
  • Ground-Level Ozone Linked to Increased Mortality
    Changes in ground-level ozone were significantly associated with an increase in deaths in many U.S. cities, according to a nationwide study conducted by researchers at the Johns Hopkins Bloomberg School of Public Health and the Yale University School of Forestry and ...More
    November 17, 2004 Posted in News
  • NIAID Launches Influenza Genome Sequencing Project
    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced a joint influenza genome sequencing project with several scientific partners. The project will help researchers understand how flu viruses evolve, ...More
    November 17, 2004 Posted in News
  • Infection Puts Extremely Low Birth Weight Infants at Risk For Developmental Delays
    Extremely low birth weight infants -- the tiniest category of premature infants -- are much more likely to experience developmental impairments if they acquire an infection during the newborn period, according to a study by the Neonatal Research Network of the National ...More
    November 17, 2004 Posted in News